• Shiehzadegan S, Alaghemand N, Fox M, Venketaraman V. Analysis of the Delta Variant B.1.617.2 COVID-19. Clin Pract. 2021 Oct 21;11(4):778-784. doi: 10.3390/clinpract11040093. PMID: 34698149; PMCID: PMC8544471. https://pubmed.ncbi.nlm.nih.gov/34698149/
  • Khatchadourian C, Sisliyan C, Nguyen K, Poladian N, Tian Q, Tamjidi F, Luong B, Singh M, Robison J, Venketaraman V. Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection. Clin Pract. 2021 Sep 22;11(4):694-707. doi: 10.3390/clinpract11040085. PMID: 34698139; PMCID: PMC8544571.https://pubmed.ncbi.nlm.nih.gov/34698139/
  • Munjal S, Munjal S, Gao J, Venketaraman V. Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients. Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077. PMID: 34563006; PMCID: PMC8482292. https://pubmed.ncbi.nlm.nih.gov/34563006/
  • Amin A, Vartanian A, Yegiazaryan A, Al-Kassir AL, Venketaraman V. Review of the Effectiveness of Various Adjuvant Therapies in Treating Mycobacterium tuberculosis. Infect Dis Rep. 2021 Sep 6;13(3):821-834. doi: 10.3390/idr13030074. PMID: 34562999; PMCID: PMC8482146. https://pubmed.ncbi.nlm.nih.gov/34562999/
  • Cao, R.; Kolloli, A.; Kumar, R.; Owens, J.; Sasaninia, K.; Vaughn, C.; Singh, M.; Truong, E.; Kachour, N.; Beever, A.; Khamas, W.; Subbian, S.; Venketaraman, V. Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection. Appl. Sci. 202111, 8274. https://doi.org/10.3390/app11178274 https://www.mdpi.com/2076-3417/11/17/8274/htm
  • To K, Cao R, Yegiazaryan A, Owens J, Nguyen T, Sasaninia K, Vaughn C, Singh M, Truong E, Medina A, Avitia E, Villegas J, Pham C, Sathananthan A, Venketaraman V. Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes. Front Cell Infect Microbiol. 2021 Jun 3;11:657775. doi: 10.3389/fcimb.2021.657775. PMID: 34150674; PMCID: PMC8211104. https://pubmed.ncbi.nlm.nih.gov/34150674/
  • Tellez D, Dayal S, Phan P, Mawley A, Shah K, Consunji G, Tellez C, Ruiz K, Sabnis R, Dayal S, Venketaraman V. Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios. Clin Pract. 2021 May 19;11(2):309-321. doi: 10.3390/clinpract11020044. PMID: 34069418; PMCID: PMC8161456. https://pubmed.ncbi.nlm.nih.gov/34069418/
  • Cao R, To K, Kachour N, Beever A, Owens J, Sathananthan A, Singh P, Kolloli A, Subbian S, Venketaraman V. Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection. Biomol Concepts. 2021 Jun 1;12(1):46-54. doi: 10.1515/bmc-2021-0006. PMID: 34062056. https://pubmed.ncbi.nlm.nih.gov/34062056/
  • To K, Cao R, Yegiazaryan A, Owens J, Sasaninia K, Vaughn C, Singh M, Truong E, Sathananthan A, Venketaraman V. The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against Mycobacterium bovis BCG Strain in Individuals with Type 2 Diabetes. Biomol Concepts. 2021 May 9;12(1):16-26. doi: 10.1515/bmc-2021-0003. PMID: 33966361.https://pubmed.ncbi.nlm.nih.gov/33966361/
  • Cho T, Khatchadourian C, Nguyen H, Dara Y, Jung S, Venketaraman V. A review of the BCG vaccine and other approaches toward tuberculosis eradication. Hum Vaccin Immunother. 2021 Aug 3;17(8):2454-2470. doi: 10.1080/21645515.2021.1885280. Epub 2021 Mar 26. PMID: 33769193; PMCID: PMC8475575. https://pubmed.ncbi.nlm.nih.gov/33769193/